Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+ Industry Domains
Report
Press Release
Blogs
Industry Statistics
Add 2 More Reports For 20% off

Report Overview

The Latin America molecular diagnostics market was valued at USD 2.74 Billion in 2025 and is expected to grow at a CAGR of 8.10%, reaching USD 5.97 Billion by 2035. The market growth is supported by the increasing awareness of molecular testing benefits, improvements in diagnostic infrastructure, and expanding applications across multiple disease areas. The growing focus on precision medicine and preventive healthcare is expected to increase the adoption of genomic and molecular tests and sustain market growth.

Key Market Trends and Insights

  • By product and services, reagents and kits secured approximately 65% market share in the historical period.
  • Based on technology, polymerase chain reaction (PCR) maintained approximately 62% of the market in the historical period.
  • By application, infectious disease remained the leading segment in the historical period.

Market Size and Forecast

  • Market Size (2025): USD 2.74 Billion
  • Projected Market Size (2035): USD 5.97 Billion
  • CAGR (2026-2035): 8.10%

Compound Annual Growth Rate

8.1%

Value in USD Billion

2026-2035


Read more about this report - Request a Free Sample

Latin America Molecular Diagnostics Market Overview

Molecular diagnostics is increasingly integrated into healthcare because of its ability to support accurate disease identification and provide clinically relevant molecular information. Developments in testing technologies are broadening its applications and improving the role of molecular analysis in diagnosis and patient care. The market was valued at USD 2.74 Billion in 2025. Across Latin America, demand for molecular diagnostics is being influenced by the growing need for accurate diagnostic solutions and advances in healthcare delivery. Increased use of molecular tests, improved laboratory infrastructure, and technological developments are supporting the market. The expanding application of these technologies in infectious disease management, oncology, and other clinical areas is also contributing to market progression.

Latin America Molecular Diagnostics Market Growth Analysis and Key Influencers

Analysis Type

Factors

Example

Market Drivers

Strengthening regional distribution and technical capabilities

In April 2024, altona Diagnostics reorganized subsidiary leadership in Argentina and Brazil, reinforcing its presence across private laboratories, hospitals, and public healthcare institutions.

Market Restraints

Insufficient laboratory infrastructure and skilled workforce

Resource-constrained healthcare facilities across Latin America may struggle to implement sophisticated testing procedures, limiting the availability and reach of molecular diagnostic services.

Market Opportunities

Strategic collaborations to improve molecular testing accuracy

In December 2025, Microbix Biosystems partnered with Seegene Mexico to support assay validation, laboratory training, and quality assurance for HPV testing.

Latin America Molecular Diagnostics Market Dynamics

The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.

Latin America Molecular Diagnostics Market Growth Drivers

Expanding Diagnostic Networks and Local Expertise to Support Market Value

The expansion of regional operations and strengthening of local expertise are supporting the development of the molecular diagnostics market across Latin America. Established distribution networks, specialized personnel, and stronger customer relationships can improve access to diagnostic technologies across laboratories and healthcare facilities. For instance, in April 2024, Altona Diagnostics announced leadership changes at its subsidiaries in Argentina and Brazil, which serve private laboratories, hospitals, and public healthcare providers. The subsidiaries offer diagnostic products for respiratory diseases, tropical fevers, emerging infections, and transplant testing, supporting regional market development.

Latin America Molecular Diagnostics Market Restraints

Limited Access to Advanced Diagnostic Technologies May Constrain Market Expansion

Uneven access to specialized laboratory infrastructure, trained personnel, and advanced testing technologies can limit the adoption of molecular diagnostics across Latin America. Healthcare facilities with limited resources may face challenges implementing sophisticated testing workflows and maintaining consistent diagnostic capacity. These constraints can delay test availability, restrict adoption outside major urban centers, and increase disparities in access to timely diagnosis. Addressing infrastructure and workforce limitations will be important for expanding molecular diagnostic testing across the region.

Latin America Molecular Diagnostics Market Opportunities

Rising Collaborations to Improve Molecular Testing Accuracy Can Expand Market Growth

Collaborations between molecular diagnostics companies and quality assessment providers create opportunities to improve testing accuracy, strengthen laboratory quality management, and expand access to infectious disease diagnostics across Latin America. For instance, in December 2025, Microbix Biosystems Inc. announced a collaboration with Seegene Mexico to support the clinical use of its Allplex and Anyplex molecular multiplex assays for detecting high-risk human papillomavirus (HPV) infections in Mexico. Microbix’s external quality assessment products (QAPs) are intended to support assay validation, laboratory training, and ongoing quality assurance. The collaboration initially focuses on HPV testing, with potential support for respiratory, sexually transmitted, and other infectious disease assays. Such initiatives may strengthen molecular testing reliability and support broader adoption across clinical laboratories.

Latin America Molecular Diagnostics Market Trends

The market is witnessing trends such as advanced molecular testing, strategic distribution partnerships, and the expansion of innovative infectious disease diagnostics.

Adoption of Advanced Molecular Testing Technologies Is Likely to Support Market Growth

The increasing development of innovative molecular assays is strengthening efforts to improve the accuracy and accessibility of infectious disease diagnosis. Advanced approaches, including CRISPR-based detection and blood-based testing, may help address limitations associated with conventional diagnostic methods. For instance, in June 2026, IntelliGenome announced a partnership with CTR Scientific to support the evaluation and potential commercialization of its CRISPR-TB blood test in Mexico. Such developments could broaden diagnostic options and contribute to the expansion of the market.

Latin America Molecular Diagnostics Market Share

Infectious Diseases Likely to Lead the Market Share by Application

The market is segmented by application into oncology, infectious diseases, genetic testing, neurological diseases, cardiovascular diseases, and others. Among these, infectious diseases are expected to represent a leading application, supported by the need for rapid pathogen identification and timely treatment decisions. For instance, in September 2025, Microbio announced a strategic distribution agreement with Abalat to introduce its InfectID-BSI molecular diagnostic platform in Mexico. The test identifies 26 pathogens associated with bloodstream infections and provides results within three hours, supporting demand for faster infectious disease diagnosis. These developments could strengthen the segment's contribution to market growth.

Read more about this report - Request a Free Sample

Latin America Molecular Diagnostics Market Analysis by Region

The regions included in the report are Brazil, Argentina, Mexico, and other Latin American countries. Brazil is expected to maintain a prominent position, supported by its research community, biotechnology activities, and engagement with molecular biology technologies. For instance, in September 2026, Hyasen Biotech announced its participation in Genética 2026, the 71st Brazilian Congress of Genetics, in Florianópolis. The company planned to showcase solutions spanning nucleic acid extraction, PCR, real-time PCR, and next-generation sequencing. Such industry engagement may support collaboration, technology awareness, and the development of molecular diagnostics capabilities, contributing to the country's market growth.

Leading Players in the Latin America Molecular Diagnostics Market

The key features of the market report include funding and investment analysis, and strategic initiatives by leading players. The major companies in the market are as follows:

CEPHEID INC.

CEPHEID INC. develops molecular diagnostic solutions, including its GeneXpert® systems, which provide sample-to-answer polymerase chain reaction (PCR) testing. Its portfolio includes the GeneXpert® Infinity, GeneXpert® Xpress, and touchscreen-enabled systems, supporting molecular testing across healthcare settings. The company contributes to the market by offering scalable testing platforms designed to deliver timely, laboratory-quality diagnostic results.

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. offers molecular analysis technologies, including the Applied Biosystems QuantStudio Absolute Q Digital PCR System. The platform supports sensitive nucleic acid detection and quantification, including rare mutation analysis, gene expression research, and liquid biopsy applications. Through its digital PCR instruments, assays, and reagents, the company contributes to the market by providing technologies for advanced molecular analysis.

ILLUMINA, INC

ILLUMINA, INC develops sequencing and genomic analysis technologies that support molecular diagnostics and life science research. Its NovaSeq X Series, including the NovaSeq X and NovaSeq X Plus systems, delivers high-throughput sequencing for applications such as whole-genome sequencing, exome analysis, and circulating tumor DNA sequencing. The company contributes to the Latin America molecular diagnostics market through scalable sequencing platforms and genomic analysis solutions.

Sysmex Corporation

Sysmex Corporation develops healthcare diagnostic technologies and laboratory solutions designed to support timely and accurate clinical decisions. Its portfolio includes hematology, urinalysis, and flow cytometry products, supported by customer service and educational resources. The company contributes to the market through its broader diagnostic technology capabilities and regional presence, although the provided information does not specify molecular diagnostic products.

Other key players in the market include F. Hoffmann-La Roche AG, Hologic Inc, BioMérieux SA, Qiagen N.V., Bitgenia S.A., and ABBOTT LABORATORIES.

*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*

Latin America Molecular Diagnostics Market Segmentation

The market report offers a detailed analysis of the market based on the following segments:

Market Breakup by Product and Services

  • Instruments
  • Reagents & Kits
  • Services & Software

The market is segmented based on the products and services that facilitate molecular testing activities. Increasing laboratory requirements, advances in diagnostic workflows, and the growing integration of molecular methods into healthcare are creating sustained demand for related solutions.

Market Breakup by Test Location

  • Point-of-Care
  • Self-test or Over the Counter

Location-based segmentation considers the different environments through which molecular diagnostic testing is made available. Changes in healthcare delivery, the need for faster diagnostic outcomes, and efforts to improve testing accessibility are shaping the utilization of molecular diagnostic services.

Market Breakup by Technology

  • Polymerase Chain Reaction (PCR)
  • In Situ Hybridization
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Mass Spectrometry
  • Sequencing
  • Others

The molecular diagnostics market in Latin America is supported by multiple technological approaches designed to provide molecular-level diagnostic information. Improvements in sensitivity, accuracy, automation, and workflow management, together with continuing technological innovation, are encouraging wider implementation across diagnostic and clinical settings.

Market Breakup by Application

  • Oncology
  • Infectious Diseases
  • Genetic Testing
  • Neurological Diseases
  • Cardiovascular Diseases
  • Others

Application segmentation reflects the varied purposes for which molecular diagnostics are incorporated into healthcare services in Latin America. Increasing demand for precise diagnosis, improved disease characterization, personalized healthcare approaches, and evidence-based clinical decisions is supporting the expansion of molecular testing applications.

Market Breakup by End User

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Others

Molecular diagnostic adoption varies according to the healthcare and diagnostic entities responsible for testing activities. Strengthening diagnostic capabilities, rising testing demand, and increasing integration of molecular solutions into routine healthcare processes are influencing utilization across different end-user categories.

Market Breakup by Country

  • Brazil
  • Argentina
  • Mexico
  • Others

The market is characterized by expanding healthcare infrastructure, increasing awareness of early disease detection, and growing demand for accurate diagnostic testing. Market growth across individual countries is supported by investments in laboratory capabilities, rising infectious disease testing needs, and the gradual adoption of advanced molecular technologies.

Key Questions Answered in the Latin America Molecular Diagnostics Market Report

  • What was the Latin America molecular diagnostics market value in 2025?
  • What is the Latin America molecular diagnostics market forecast outlook for 2026-2035?
  • What are the major factors aiding the Latin America molecular diagnostics market demand?
  • How has the market performed so far, and how is it anticipated to perform in the coming years?
  • What are the market's major drivers, opportunities, and restraints?
  • What are the major molecular diagnostics market trends?
  • Which product and services type is expected to dominate the market segment?
  • Which test location is projected to lead the market segment?
  • Which technology is anticipated to drive the market segment?
  • Which application is likely to dominate the market segment?
  • Which end user is expected to dominate the market segment?
  • Who are the key players involved in the Latin America molecular diagnostics market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

Research Methodology

This report is developed through a robust mixed-methods research design combining:

  • Primary Research: Interviews with molecular diagnostics experts, clinical laboratory directors, pathologists, healthcare procurement managers, and distributors across key Latin American markets to assess testing demand, technology adoption, purchasing patterns, and reimbursement challenges.
  • Secondary Research: Analysis of peer-reviewed publications, clinical studies, epidemiological data, and regulatory information from the World Health Organization (WHO), Pan American Health Organization (PAHO), and relevant national health authorities. Company websites, product portfolios, annual reports, and diagnostic technology updates are also reviewed to evaluate competitive positioning and product developments.
  • Validation: Quantitative estimates are triangulated through top-down and bottom-up market modeling, supported by cross-verification of secondary data, country-level market indicators, and expert insights to improve consistency and reliability.

More Insights on

Vehicle Diagnostics Market

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

REPORT FEATURES DETAILS
Base Year 2025
Historical Period 2019-2025
Forecast Period 2026-2035
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product and Services
  • Test Location
  • Technology
  • Application
  • End User
  • Region
Breakup by Product and Services
  • Instruments
  • Reagents & Kits
  • Services & Software
Breakup by Test Location
  • Point-of-Care
  • Self-test or Over the Counter
Breakup by Technology
  • Polymerase Chain Reaction (PCR)
  • In Situ Hybridization
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Mass Spectrometry
  • Sequencing
  • Others
Breakup by Application
  • Oncology
  • Infectious Diseases
  • Genetic Testing
  • Neurological Diseases
  • Cardiovascular Diseases
  • Others
Breakup by End User
  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Others
Breakup by Region
  • Brazil
  • Argentina
  • Mexico
  • Others
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • PESTEL Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Company News and Developments
    • Certifications
Companies Covered
  • CEPHEID INC.
  • F. Hoffmann-La Roche AG
  • Thermo Fisher Scientific Inc.
  • Hologic Inc
  • ILLUMINA, INC
  • BioMérieux SA
  • QIAGEN N.V.
  • ABBOTT LABORATORIES
  • Sysmex Corporation
  • Bitgenia S.A.

Datasheet

10 % Off

USD

2,699

2,429

Single User License

10 % Off

USD

4,299

3,869

Five User License

15 % Off

USD

5,799

4,949

Corporate License

15 % Off

USD

6,999

5,949

Datasheet

One User

USD 2,699

USD 2,429

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 4,299

USD 3,869

tax inclusive*

  • All Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 5,799

USD 4,949

tax inclusive*

  • All Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 6,999

USD 5,949

tax inclusive*

  • All Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

This is a collaborative report by Vishakha Agrawal reflecting perspectives and research-driven insights from Expert Market Research.

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

License Type

Select License Type

Choose the right license for your needs and access rights.

shopping cart

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Bookmark Icon

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us